Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-26 Sale |
2021-08-30 5:16 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $35.75 | $275,787 | 232,970 (Direct) |
View |
| 2021-08-13 Sale |
2021-08-17 4:44 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
2,286 | $35.07 | $80,161 | 250,324 (Direct) |
View |
| 2021-07-27 Sale |
2021-07-29 7:27 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $35.47 | $709,380 | 209,380 (Direct) |
View |
| 2021-05-07 Sale |
2021-05-11 6:46 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $40.82 | $408,192 | 229,380 (Direct) |
View |
| 2021-04-08 Sale |
2021-04-15 7:14 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
4,630 | $38.34 | $177,504 | 239,380 (Direct) |
View |
| 2021-04-07 Sale |
2021-04-09 5:55 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
15,370 | $39.31 | $604,144 | 244,010 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-04 Option Award |
2025-02-05 4:32 pm |
N/A 2035-02-04 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 6:07 pm |
N/A 2034-02-28 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:08 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:12 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 5:16 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $0 | 232,970 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 5:16 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $1.43 | 232,970 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
558 | $1.89 | 250,324 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
2,286 | $0 | 250,324 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
1,728 | $1.43 | 250,324 (Direct) |
View |
| 2021-07-27 Exercise |
2021-07-29 7:27 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $0 | 209,380 (Direct) |
View |
| 2021-07-27 Exercise |
2021-07-29 7:27 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $1.43 | 209,380 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:17 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 6:46 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $0 | 229,380 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 6:46 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $1.43 | 229,380 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-15 7:14 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
4,630 | $1.43 | 239,380 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-15 7:14 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
4,630 | $0 | 239,380 (Direct) |
View |
| 2021-04-07 Option Award |
2021-04-09 5:55 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
15,370 | $1.43 | 244,010 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 5:55 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
15,370 | $0 | 244,010 (Direct) |
View |
Ownership |
2020-09-24 7:29 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
0 | $0 | 531,728 (Direct) |
View |